» Articles » PMID: 30558209

The Complex Interplay Between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2018 Dec 19
PMID 30558209
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Lipids and inflammation regulate each other. Early studies on this topic focused on the systemic effects that the acute inflammatory response-and interleukins-had on lipid metabolism. Today, in the era of the obesity epidemic, whose primary complications are cardio-metabolic diseases, attention has moved to the effects that the nutritional environment and lipid derangements have on peripheral tissues, where lipotoxicity leads to organ damage through an imbalance of chronic inflammatory responses. After an overview of the effects that acute inflammation has on the systemic lipid metabolism, this review will describe the lipid-induced immune responses that take place in peripheral tissues and lead to chronic cardio-metabolic diseases. Moreover, the anti-inflammatory effects of lipid lowering drugs, as well as the possibility of using anti-inflammatory agents against cardio-metabolic diseases, will be discussed.

Citing Articles

Mediating role of blood metabolites in the relationship between immune cell traits and sepsis: a Mendelian randomization and mediation analysis.

Liu Y, Cao Y Inflamm Res. 2025; 74(1):5.

PMID: 39762630 DOI: 10.1007/s00011-024-01971-9.


Longitudinal changes in remnant cholesterol and the risk of cardiovascular disease.

Zhang Y, Xu Q, Tian X, Xia X, Chen S, Liu F Cardiovasc Diabetol. 2025; 24(1):1.

PMID: 39748387 PMC: 11697916. DOI: 10.1186/s12933-024-02556-w.


A methodology for gene level omics-WAS integration identifies genes influencing traits associated with cardiovascular risks: the Long Life Family Study.

Acharya S, Liao S, Jung W, Kang Y, Akbary Moghaddam V, Feitosa M Hum Genet. 2024; 143(9-10):1241-1252.

PMID: 39276247 PMC: 11485042. DOI: 10.1007/s00439-024-02701-1.


Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals.

Vass Z, Shenker-Horvath K, Banyai B, Veto K, Torok V, Gem J Int J Mol Sci. 2024; 25(17).

PMID: 39273484 PMC: 11395437. DOI: 10.3390/ijms25179537.


The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.

Hsu C, Abdulrahim M, Mustafa M, Omar T, Balto F, Pineda I Med Oncol. 2024; 41(8):202.

PMID: 39008137 DOI: 10.1007/s12032-024-02435-0.


References
1.
Rheinheimer J, de Souza B, Cardoso N, Bauer A, Crispim D . Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review. Metabolism. 2017; 74:1-9. DOI: 10.1016/j.metabol.2017.06.002. View

2.
Berglund L, Brunzell J, Goldberg A, Goldberg I, Sacks F, Murad M . Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(9):2969-89. PMC: 3431581. DOI: 10.1210/jc.2011-3213. View

3.
Chan K, Pillon N, Sivaloganathan D, Costford S, Liu Z, Theret M . Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK). J Biol Chem. 2015; 290(27):16979-88. PMC: 4505442. DOI: 10.1074/jbc.M115.646992. View

4.
Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P . Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ Res. 2008; 103(12):1402-9. PMC: 2994199. DOI: 10.1161/CIRCRESAHA.108.178426. View

5.
Gordon B, Parker T, Levine D, Saal S, Wang J, SLOAN B . Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001; 29(8):1563-8. DOI: 10.1097/00003246-200108000-00011. View